comparemela.com
2
3
4
5
6
7
8
Latest Breaking News On - Anti pd 1 - Page 1 : comparemela.com
Treating Patients with High-Risk Melanoma
A comprehensive overview of treatment approaches for patients with high-risk melanoma.
Nikhil-khushalani
Annac-pavlick
Sunandana-chandra
Unresectable-metastatic-melanoma
High-risk-melanoma
Ipilimumab
Anti-pd-1
Braf-mek
Stage-iii-disease
Resected-stage-iv
Pembrolizumab
Tumor-Directed Oncolytic Therapies for Melanoma and CSCC
An expert panel discusses the use of tumor-directed oncolytic therapies for melanoma and cutaneous squamous cell carcinoma.
Nikhil-khushalani
Sunandana-chandra
Cutaneous-squamous-cell-carcinoma
Unresectable-metastatic-melanoma
Tumor-directed-oncolytic-therapies
T-vec
Cemiplimab
Anti-pd-1
Intralesional-therapy
Deciding Between Melanoma Therapy Options
A panel of skin cancer experts share their thoughts on treatment selection for patients with melanoma.
Sunandana-chandra
Annac-pavlick
Nikhil-khushalani
Unresectable-metastatic-melanoma
Combination-immunotherapy
Toxicity
Ipilimumab
Nivolumab
Anti-pd-1
Braf-mutations
Triplet-therapy
BRAF/MEK Dual Inhibitors for Melanoma
An expert panel analyzes BRAF/MEK dual inhibitor therapy for the treatment of melanoma.
Sunandana-chandra
Nikhil-khushalani
Clinical-oncology
Unresectable-metastatic-melanoma
Dreamseq-trial
Combination-immunotherapy
Braf-mek
Targeted-therapy
Second-line-treatment
Ipilimumab
Nivolumab
Factors that Impact Treatment Selection for Melanoma
Anna C. Pavlick, DO, discusses factors that impact treatment selection for patients with melanoma.
Sunandana-chandra
Annac-pavlick
Unresectable-metastatic-melanoma
Performance-status
Disease-burden
Braf-mutation
Dreamseq-trial
Immunotherapy
Anti-pd-1
Anti-ctla4
Mutation-status
vimarsana © 2020. All Rights Reserved.